Inhaled Corticosteroid Market
1 Study Coverage
1.1 Inhaled Corticosteroid Product Introduction
1.2 Market by Type
1.2.1 Global Inhaled Corticosteroid Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Beclomethasone Dipropionate
1.2.3 Budesonide
1.2.4 Fluticasone Inhaler Powder
1.2.5 Mometasone
1.2.6 Others
1.3 Market by Application
1.3.1 Global Inhaled Corticosteroid Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Respiratory Care Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Inhaled Corticosteroid Sales Estimates and Forecasts 2017-2028
2.2 Global Inhaled Corticosteroid Revenue Estimates and Forecasts 2017-2028
2.3 Global Inhaled Corticosteroid Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Inhaled Corticosteroid Sales by Region
2.4.1 Global Inhaled Corticosteroid Sales by Region (2017-2022)
2.4.2 Global Sales Inhaled Corticosteroid by Region (2023-2028)
2.5 Global Inhaled Corticosteroid Revenue by Region
2.5.1 Global Inhaled Corticosteroid Revenue by Region (2017-2022)
2.5.2 Global Inhaled Corticosteroid Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Inhaled Corticosteroid Sales by Manufacturers
3.1.1 Global Top Inhaled Corticosteroid Manufacturers by Sales (2017-2022)
3.1.2 Global Inhaled Corticosteroid Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Inhaled Corticosteroid in 2021
3.2 Global Inhaled Corticosteroid Revenue by Manufacturers
3.2.1 Global Inhaled Corticosteroid Revenue by Manufacturers (2017-2022)
3.2.2 Global Inhaled Corticosteroid Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Inhaled Corticosteroid Revenue in 2021
3.3 Global Inhaled Corticosteroid Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Inhaled Corticosteroid Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Inhaled Corticosteroid Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Inhaled Corticosteroid Sales by Type
4.1.1 Global Inhaled Corticosteroid Historical Sales by Type (2017-2022)
4.1.2 Global Inhaled Corticosteroid Forecasted Sales by Type (2023-2028)
4.1.3 Global Inhaled Corticosteroid Sales Market Share by Type (2017-2028)
4.2 Global Inhaled Corticosteroid Revenue by Type
4.2.1 Global Inhaled Corticosteroid Historical Revenue by Type (2017-2022)
4.2.2 Global Inhaled Corticosteroid Forecasted Revenue by Type (2023-2028)
4.2.3 Global Inhaled Corticosteroid Revenue Market Share by Type (2017-2028)
4.3 Global Inhaled Corticosteroid Price by Type
4.3.1 Global Inhaled Corticosteroid Price by Type (2017-2022)
4.3.2 Global Inhaled Corticosteroid Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Inhaled Corticosteroid Sales by Application
5.1.1 Global Inhaled Corticosteroid Historical Sales by Application (2017-2022)
5.1.2 Global Inhaled Corticosteroid Forecasted Sales by Application (2023-2028)
5.1.3 Global Inhaled Corticosteroid Sales Market Share by Application (2017-2028)
5.2 Global Inhaled Corticosteroid Revenue by Application
5.2.1 Global Inhaled Corticosteroid Historical Revenue by Application (2017-2022)
5.2.2 Global Inhaled Corticosteroid Forecasted Revenue by Application (2023-2028)
5.2.3 Global Inhaled Corticosteroid Revenue Market Share by Application (2017-2028)
5.3 Global Inhaled Corticosteroid Price by Application
5.3.1 Global Inhaled Corticosteroid Price by Application (2017-2022)
5.3.2 Global Inhaled Corticosteroid Price Forecast by Application (2023-2028)
6 North America
6.1 North America Inhaled Corticosteroid Market Size by Type
6.1.1 North America Inhaled Corticosteroid Sales by Type (2017-2028)
6.1.2 North America Inhaled Corticosteroid Revenue by Type (2017-2028)
6.2 North America Inhaled Corticosteroid Market Size by Application
6.2.1 North America Inhaled Corticosteroid Sales by Application (2017-2028)
6.2.2 North America Inhaled Corticosteroid Revenue by Application (2017-2028)
6.3 North America Inhaled Corticosteroid Market Size by Country
6.3.1 North America Inhaled Corticosteroid Sales by Country (2017-2028)
6.3.2 North America Inhaled Corticosteroid Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Inhaled Corticosteroid Market Size by Type
7.1.1 Europe Inhaled Corticosteroid Sales by Type (2017-2028)
7.1.2 Europe Inhaled Corticosteroid Revenue by Type (2017-2028)
7.2 Europe Inhaled Corticosteroid Market Size by Application
7.2.1 Europe Inhaled Corticosteroid Sales by Application (2017-2028)
7.2.2 Europe Inhaled Corticosteroid Revenue by Application (2017-2028)
7.3 Europe Inhaled Corticosteroid Market Size by Country
7.3.1 Europe Inhaled Corticosteroid Sales by Country (2017-2028)
7.3.2 Europe Inhaled Corticosteroid Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Inhaled Corticosteroid Market Size by Type
8.1.1 Asia Pacific Inhaled Corticosteroid Sales by Type (2017-2028)
8.1.2 Asia Pacific Inhaled Corticosteroid Revenue by Type (2017-2028)
8.2 Asia Pacific Inhaled Corticosteroid Market Size by Application
8.2.1 Asia Pacific Inhaled Corticosteroid Sales by Application (2017-2028)
8.2.2 Asia Pacific Inhaled Corticosteroid Revenue by Application (2017-2028)
8.3 Asia Pacific Inhaled Corticosteroid Market Size by Region
8.3.1 Asia Pacific Inhaled Corticosteroid Sales by Region (2017-2028)
8.3.2 Asia Pacific Inhaled Corticosteroid Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Inhaled Corticosteroid Market Size by Type
9.1.1 Latin America Inhaled Corticosteroid Sales by Type (2017-2028)
9.1.2 Latin America Inhaled Corticosteroid Revenue by Type (2017-2028)
9.2 Latin America Inhaled Corticosteroid Market Size by Application
9.2.1 Latin America Inhaled Corticosteroid Sales by Application (2017-2028)
9.2.2 Latin America Inhaled Corticosteroid Revenue by Application (2017-2028)
9.3 Latin America Inhaled Corticosteroid Market Size by Country
9.3.1 Latin America Inhaled Corticosteroid Sales by Country (2017-2028)
9.3.2 Latin America Inhaled Corticosteroid Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Inhaled Corticosteroid Market Size by Type
10.1.1 Middle East and Africa Inhaled Corticosteroid Sales by Type (2017-2028)
10.1.2 Middle East and Africa Inhaled Corticosteroid Revenue by Type (2017-2028)
10.2 Middle East and Africa Inhaled Corticosteroid Market Size by Application
10.2.1 Middle East and Africa Inhaled Corticosteroid Sales by Application (2017-2028)
10.2.2 Middle East and Africa Inhaled Corticosteroid Revenue by Application (2017-2028)
10.3 Middle East and Africa Inhaled Corticosteroid Market Size by Country
10.3.1 Middle East and Africa Inhaled Corticosteroid Sales by Country (2017-2028)
10.3.2 Middle East and Africa Inhaled Corticosteroid Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sumitomo
11.1.1 Sumitomo Corporation Information
11.1.2 Sumitomo Overview
11.1.3 Sumitomo Inhaled Corticosteroid Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sumitomo Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sumitomo Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Inhaled Corticosteroid Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Overview
11.3.3 Novartis Inhaled Corticosteroid Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Novartis Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis Recent Developments
11.4 Merck
11.4.1 Merck Corporation Information
11.4.2 Merck Overview
11.4.3 Merck Inhaled Corticosteroid Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Merck Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Merck Recent Developments
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Overview
11.5.3 Sanofi Inhaled Corticosteroid Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Sanofi Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sanofi Recent Developments
11.6 Johnson and Johnson
11.6.1 Johnson and Johnson Corporation Information
11.6.2 Johnson and Johnson Overview
11.6.3 Johnson and Johnson Inhaled Corticosteroid Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Johnson and Johnson Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Johnson and Johnson Recent Developments
11.7 GSK
11.7.1 GSK Corporation Information
11.7.2 GSK Overview
11.7.3 GSK Inhaled Corticosteroid Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 GSK Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 GSK Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Corporation Information
11.8.2 AstraZeneca Overview
11.8.3 AstraZeneca Inhaled Corticosteroid Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 AstraZeneca Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 AstraZeneca Recent Developments
11.9 Teijin
11.9.1 Teijin Corporation Information
11.9.2 Teijin Overview
11.9.3 Teijin Inhaled Corticosteroid Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Teijin Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Teijin Recent Developments
11.10 Glaxo's Advair
11.10.1 Glaxo's Advair Corporation Information
11.10.2 Glaxo's Advair Overview
11.10.3 Glaxo's Advair Inhaled Corticosteroid Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Glaxo's Advair Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Glaxo's Advair Recent Developments
11.11 Amgen
11.11.1 Amgen Corporation Information
11.11.2 Amgen Overview
11.11.3 Amgen Inhaled Corticosteroid Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Amgen Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Amgen Recent Developments
11.12 Kos Pharmaceutical
11.12.1 Kos Pharmaceutical Corporation Information
11.12.2 Kos Pharmaceutical Overview
11.12.3 Kos Pharmaceutical Inhaled Corticosteroid Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Kos Pharmaceutical Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Kos Pharmaceutical Recent Developments
11.13 Teva Pharmaceutical
11.13.1 Teva Pharmaceutical Corporation Information
11.13.2 Teva Pharmaceutical Overview
11.13.3 Teva Pharmaceutical Inhaled Corticosteroid Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Teva Pharmaceutical Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Teva Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Inhaled Corticosteroid Industry Chain Analysis
12.2 Inhaled Corticosteroid Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Inhaled Corticosteroid Production Mode & Process
12.4 Inhaled Corticosteroid Sales and Marketing
12.4.1 Inhaled Corticosteroid Sales Channels
12.4.2 Inhaled Corticosteroid Distributors
12.5 Inhaled Corticosteroid Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Inhaled Corticosteroid Industry Trends
13.2 Inhaled Corticosteroid Market Drivers
13.3 Inhaled Corticosteroid Market Challenges
13.4 Inhaled Corticosteroid Market Restraints
14 Key Findings in The Global Inhaled Corticosteroid Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Inhaled Corticosteroid Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Beclomethasone Dipropionate
Table 3. Major Manufacturers of Budesonide
Table 4. Major Manufacturers of Fluticasone Inhaler Powder
Table 5. Major Manufacturers of Mometasone
Table 6. Major Manufacturers of Others
Table 7. Global Inhaled Corticosteroid Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Inhaled Corticosteroid Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Inhaled Corticosteroid Sales by Region (2017-2022) & (MT)
Table 10. Global Inhaled Corticosteroid Sales Market Share by Region (2017-2022)
Table 11. Global Inhaled Corticosteroid Sales by Region (2023-2028) & (MT)
Table 12. Global Inhaled Corticosteroid Sales Market Share by Region (2023-2028)
Table 13. Global Inhaled Corticosteroid Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Inhaled Corticosteroid Revenue Market Share by Region (2017-2022)
Table 15. Global Inhaled Corticosteroid Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Inhaled Corticosteroid Revenue Market Share by Region (2023-2028)
Table 17. Global Inhaled Corticosteroid Sales by Manufacturers (2017-2022) & (MT)
Table 18. Global Inhaled Corticosteroid Sales Share by Manufacturers (2017-2022)
Table 19. Global Inhaled Corticosteroid Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Inhaled Corticosteroid Revenue Share by Manufacturers (2017-2022)
Table 21. Inhaled Corticosteroid Price by Manufacturers (2017-2022) &(USD/MT)
Table 22. Global Inhaled Corticosteroid Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Inhaled Corticosteroid by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhaled Corticosteroid as of 2021)
Table 24. Inhaled Corticosteroid Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Inhaled Corticosteroid Product Offered
Table 26. Date of Manufacturers Enter into Inhaled Corticosteroid Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Inhaled Corticosteroid Sales by Type (2017-2022) & (MT)
Table 29. Global Inhaled Corticosteroid Sales by Type (2023-2028) & (MT)
Table 30. Global Inhaled Corticosteroid Sales Share by Type (2017-2022)
Table 31. Global Inhaled Corticosteroid Sales Share by Type (2023-2028)
Table 32. Global Inhaled Corticosteroid Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Inhaled Corticosteroid Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Inhaled Corticosteroid Revenue Share by Type (2017-2022)
Table 35. Global Inhaled Corticosteroid Revenue Share by Type (2023-2028)
Table 36. Inhaled Corticosteroid Price by Type (2017-2022) & (USD/MT)
Table 37. Global Inhaled Corticosteroid Price Forecast by Type (2023-2028) & (USD/MT)
Table 38. Global Inhaled Corticosteroid Sales by Application (2017-2022) & (MT)
Table 39. Global Inhaled Corticosteroid Sales by Application (2023-2028) & (MT)
Table 40. Global Inhaled Corticosteroid Sales Share by Application (2017-2022)
Table 41. Global Inhaled Corticosteroid Sales Share by Application (2023-2028)
Table 42. Global Inhaled Corticosteroid Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Inhaled Corticosteroid Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Inhaled Corticosteroid Revenue Share by Application (2017-2022)
Table 45. Global Inhaled Corticosteroid Revenue Share by Application (2023-2028)
Table 46. Inhaled Corticosteroid Price by Application (2017-2022) & (USD/MT)
Table 47. Global Inhaled Corticosteroid Price Forecast by Application (2023-2028) & (USD/MT)
Table 48. North America Inhaled Corticosteroid Sales by Type (2017-2022) & (MT)
Table 49. North America Inhaled Corticosteroid Sales by Type (2023-2028) & (MT)
Table 50. North America Inhaled Corticosteroid Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Inhaled Corticosteroid Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Inhaled Corticosteroid Sales by Application (2017-2022) & (MT)
Table 53. North America Inhaled Corticosteroid Sales by Application (2023-2028) & (MT)
Table 54. North America Inhaled Corticosteroid Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Inhaled Corticosteroid Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Inhaled Corticosteroid Sales by Country (2017-2022) & (MT)
Table 57. North America Inhaled Corticosteroid Sales by Country (2023-2028) & (MT)
Table 58. North America Inhaled Corticosteroid Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Inhaled Corticosteroid Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Inhaled Corticosteroid Sales by Type (2017-2022) & (MT)
Table 61. Europe Inhaled Corticosteroid Sales by Type (2023-2028) & (MT)
Table 62. Europe Inhaled Corticosteroid Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Inhaled Corticosteroid Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Inhaled Corticosteroid Sales by Application (2017-2022) & (MT)
Table 65. Europe Inhaled Corticosteroid Sales by Application (2023-2028) & (MT)
Table 66. Europe Inhaled Corticosteroid Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Inhaled Corticosteroid Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Inhaled Corticosteroid Sales by Country (2017-2022) & (MT)
Table 69. Europe Inhaled Corticosteroid Sales by Country (2023-2028) & (MT)
Table 70. Europe Inhaled Corticosteroid Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Inhaled Corticosteroid Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Inhaled Corticosteroid Sales by Type (2017-2022) & (MT)
Table 73. Asia Pacific Inhaled Corticosteroid Sales by Type (2023-2028) & (MT)
Table 74. Asia Pacific Inhaled Corticosteroid Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Inhaled Corticosteroid Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Inhaled Corticosteroid Sales by Application (2017-2022) & (MT)
Table 77. Asia Pacific Inhaled Corticosteroid Sales by Application (2023-2028) & (MT)
Table 78. Asia Pacific Inhaled Corticosteroid Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Inhaled Corticosteroid Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Inhaled Corticosteroid Sales by Region (2017-2022) & (MT)
Table 81. Asia Pacific Inhaled Corticosteroid Sales by Region (2023-2028) & (MT)
Table 82. Asia Pacific Inhaled Corticosteroid Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Inhaled Corticosteroid Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Inhaled Corticosteroid Sales by Type (2017-2022) & (MT)
Table 85. Latin America Inhaled Corticosteroid Sales by Type (2023-2028) & (MT)
Table 86. Latin America Inhaled Corticosteroid Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Inhaled Corticosteroid Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Inhaled Corticosteroid Sales by Application (2017-2022) & (MT)
Table 89. Latin America Inhaled Corticosteroid Sales by Application (2023-2028) & (MT)
Table 90. Latin America Inhaled Corticosteroid Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Inhaled Corticosteroid Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Inhaled Corticosteroid Sales by Country (2017-2022) & (MT)
Table 93. Latin America Inhaled Corticosteroid Sales by Country (2023-2028) & (MT)
Table 94. Latin America Inhaled Corticosteroid Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Inhaled Corticosteroid Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Inhaled Corticosteroid Sales by Type (2017-2022) & (MT)
Table 97. Middle East and Africa Inhaled Corticosteroid Sales by Type (2023-2028) & (MT)
Table 98. Middle East and Africa Inhaled Corticosteroid Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Inhaled Corticosteroid Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Inhaled Corticosteroid Sales by Application (2017-2022) & (MT)
Table 101. Middle East and Africa Inhaled Corticosteroid Sales by Application (2023-2028) & (MT)
Table 102. Middle East and Africa Inhaled Corticosteroid Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Inhaled Corticosteroid Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Inhaled Corticosteroid Sales by Country (2017-2022) & (MT)
Table 105. Middle East and Africa Inhaled Corticosteroid Sales by Country (2023-2028) & (MT)
Table 106. Middle East and Africa Inhaled Corticosteroid Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Inhaled Corticosteroid Revenue by Country (2023-2028) & (US$ Million)
Table 108. Sumitomo Corporation Information
Table 109. Sumitomo Description and Major Businesses
Table 110. Sumitomo Inhaled Corticosteroid Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 111. Sumitomo Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Sumitomo Recent Developments
Table 113. Pfizer Corporation Information
Table 114. Pfizer Description and Major Businesses
Table 115. Pfizer Inhaled Corticosteroid Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 116. Pfizer Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Pfizer Recent Developments
Table 118. Novartis Corporation Information
Table 119. Novartis Description and Major Businesses
Table 120. Novartis Inhaled Corticosteroid Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 121. Novartis Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Novartis Recent Developments
Table 123. Merck Corporation Information
Table 124. Merck Description and Major Businesses
Table 125. Merck Inhaled Corticosteroid Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 126. Merck Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Merck Recent Developments
Table 128. Sanofi Corporation Information
Table 129. Sanofi Description and Major Businesses
Table 130. Sanofi Inhaled Corticosteroid Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 131. Sanofi Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Sanofi Recent Developments
Table 133. Johnson and Johnson Corporation Information
Table 134. Johnson and Johnson Description and Major Businesses
Table 135. Johnson and Johnson Inhaled Corticosteroid Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 136. Johnson and Johnson Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Johnson and Johnson Recent Developments
Table 138. GSK Corporation Information
Table 139. GSK Description and Major Businesses
Table 140. GSK Inhaled Corticosteroid Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 141. GSK Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. GSK Recent Developments
Table 143. AstraZeneca Corporation Information
Table 144. AstraZeneca Description and Major Businesses
Table 145. AstraZeneca Inhaled Corticosteroid Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 146. AstraZeneca Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. AstraZeneca Recent Developments
Table 148. Teijin Corporation Information
Table 149. Teijin Description and Major Businesses
Table 150. Teijin Inhaled Corticosteroid Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 151. Teijin Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Teijin Recent Developments
Table 153. Glaxo's Advair Corporation Information
Table 154. Glaxo's Advair Description and Major Businesses
Table 155. Glaxo's Advair Inhaled Corticosteroid Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 156. Glaxo's Advair Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Glaxo's Advair Recent Developments
Table 158. Amgen Corporation Information
Table 159. Amgen Description and Major Businesses
Table 160. Amgen Inhaled Corticosteroid Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 161. Amgen Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Amgen Recent Developments
Table 163. Kos Pharmaceutical Corporation Information
Table 164. Kos Pharmaceutical Description and Major Businesses
Table 165. Kos Pharmaceutical Inhaled Corticosteroid Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 166. Kos Pharmaceutical Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Kos Pharmaceutical Recent Developments
Table 168. Teva Pharmaceutical Corporation Information
Table 169. Teva Pharmaceutical Description and Major Businesses
Table 170. Teva Pharmaceutical Inhaled Corticosteroid Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 171. Teva Pharmaceutical Inhaled Corticosteroid Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Teva Pharmaceutical Recent Developments
Table 173. Key Raw Materials Lists
Table 174. Raw Materials Key Suppliers Lists
Table 175. Inhaled Corticosteroid Distributors List
Table 176. Inhaled Corticosteroid Customers List
Table 177. Inhaled Corticosteroid Market Trends
Table 178. Inhaled Corticosteroid Market Drivers
Table 179. Inhaled Corticosteroid Market Challenges
Table 180. Inhaled Corticosteroid Market Restraints
Table 181. Research Programs/Design for This Report
Table 182. Key Data Information from Secondary Sources
Table 183. Key Data Information from Primary Sources
List of Figures
Figure 1. Inhaled Corticosteroid Product Picture
Figure 3. Global Inhaled Corticosteroid Market Share by Type in 2021 & 2028
Figure 3. Beclomethasone Dipropionate Product Picture
Figure 4. Budesonide Product Picture
Figure 5. Fluticasone Inhaler Powder Product Picture
Figure 6. Mometasone Product Picture
Figure 7. Others Product Picture
Figure 8. Global Inhaled Corticosteroid Market Share by Application in 2021 & 2028
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Respiratory Care Centers
Figure 12. Others
Figure 13. Inhaled Corticosteroid Report Years Considered
Figure 14. Global Inhaled Corticosteroid Sales 2017-2028 (MT)
Figure 15. Global Inhaled Corticosteroid Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Inhaled Corticosteroid Revenue 2017-2028 (US$ Million)
Figure 17. Global Inhaled Corticosteroid Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 18. Global Inhaled Corticosteroid Sales Market Share by Region (2017-2022)
Figure 19. Global Inhaled Corticosteroid Sales Market Share by Region (2023-2028)
Figure 20. North America Inhaled Corticosteroid Sales YoY (2017-2028) & (MT)
Figure 21. North America Inhaled Corticosteroid Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Europe Inhaled Corticosteroid Sales YoY (2017-2028) & (MT)
Figure 23. Europe Inhaled Corticosteroid Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Asia-Pacific Inhaled Corticosteroid Sales YoY (2017-2028) & (MT)
Figure 25. Asia-Pacific Inhaled Corticosteroid Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Latin America Inhaled Corticosteroid Sales YoY (2017-2028) & (MT)
Figure 27. Latin America Inhaled Corticosteroid Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Middle East & Africa Inhaled Corticosteroid Sales YoY (2017-2028) & (MT)
Figure 29. Middle East & Africa Inhaled Corticosteroid Revenue YoY (2017-2028) & (US$ Million)
Figure 30. The Inhaled Corticosteroid Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 31. The Top 5 and 10 Largest Manufacturers of Inhaled Corticosteroid in the World: Market Share by Inhaled Corticosteroid Revenue in 2021
Figure 32. Global Inhaled Corticosteroid Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 33. Global Inhaled Corticosteroid Sales Market Share by Type (2017-2028)
Figure 34. Global Inhaled Corticosteroid Revenue Market Share by Type (2017-2028)
Figure 35. Global Inhaled Corticosteroid Sales Market Share by Application (2017-2028)
Figure 36. Global Inhaled Corticosteroid Revenue Market Share by Application (2017-2028)
Figure 37. North America Inhaled Corticosteroid Sales Market Share by Type (2017-2028)
Figure 38. North America Inhaled Corticosteroid Revenue Market Share by Type (2017-2028)
Figure 39. North America Inhaled Corticosteroid Sales Market Share by Application (2017-2028)
Figure 40. North America Inhaled Corticosteroid Revenue Market Share by Application (2017-2028)
Figure 41. North America Inhaled Corticosteroid Sales Share by Country (2017-2028)
Figure 42. North America Inhaled Corticosteroid Revenue Share by Country (2017-2028)
Figure 43. U.S. Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
Figure 44. Canada Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
Figure 45. Europe Inhaled Corticosteroid Sales Market Share by Type (2017-2028)
Figure 46. Europe Inhaled Corticosteroid Revenue Market Share by Type (2017-2028)
Figure 47. Europe Inhaled Corticosteroid Sales Market Share by Application (2017-2028)
Figure 48. Europe Inhaled Corticosteroid Revenue Market Share by Application (2017-2028)
Figure 49. Europe Inhaled Corticosteroid Sales Share by Country (2017-2028)
Figure 50. Europe Inhaled Corticosteroid Revenue Share by Country (2017-2028)
Figure 51. Germany Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
Figure 52. France Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
Figure 53. U.K. Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
Figure 54. Italy Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
Figure 55. Russia Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
Figure 56. Asia Pacific Inhaled Corticosteroid Sales Market Share by Type (2017-2028)
Figure 57. Asia Pacific Inhaled Corticosteroid Revenue Market Share by Type (2017-2028)
Figure 58. Asia Pacific Inhaled Corticosteroid Sales Market Share by Application (2017-2028)
Figure 59. Asia Pacific Inhaled Corticosteroid Revenue Market Share by Application (2017-2028)
Figure 60. Asia Pacific Inhaled Corticosteroid Sales Share by Region (2017-2028)
Figure 61. Asia Pacific Inhaled Corticosteroid Revenue Share by Region (2017-2028)
Figure 62. China Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
Figure 63. Japan Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
Figure 64. South Korea Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
Figure 65. India Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
Figure 66. Australia Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
Figure 67. Taiwan Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
Figure 68. Indonesia Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
Figure 69. Thailand Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
Figure 70. Malaysia Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
Figure 71. Philippines Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
Figure 72. Latin America Inhaled Corticosteroid Sales Market Share by Type (2017-2028)
Figure 73. Latin America Inhaled Corticosteroid Revenue Market Share by Type (2017-2028)
Figure 74. Latin America Inhaled Corticosteroid Sales Market Share by Application (2017-2028)
Figure 75. Latin America Inhaled Corticosteroid Revenue Market Share by Application (2017-2028)
Figure 76. Latin America Inhaled Corticosteroid Sales Share by Country (2017-2028)
Figure 77. Latin America Inhaled Corticosteroid Revenue Share by Country (2017-2028)
Figure 78. Mexico Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
Figure 79. Brazil Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
Figure 80. Argentina Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
Figure 81. Middle East and Africa Inhaled Corticosteroid Sales Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Inhaled Corticosteroid Revenue Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Inhaled Corticosteroid Sales Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Inhaled Corticosteroid Revenue Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Inhaled Corticosteroid Sales Share by Country (2017-2028)
Figure 86. Middle East and Africa Inhaled Corticosteroid Revenue Share by Country (2017-2028)
Figure 87. Turkey Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
Figure 88. Saudi Arabia Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
Figure 89. U.A.E Inhaled Corticosteroid Revenue (2017-2028) & (US$ Million)
Figure 90. Inhaled Corticosteroid Value Chain
Figure 91. Inhaled Corticosteroid Production Process
Figure 92. Channels of Distribution
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed
Industry Market Size
